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Musculoskeletal Radiology: Anatomic and Molecular Imaging
A high level of sophistication has been achieved with current clinical musculoskeletal imaging modalities. For example, the application of MRI for the evaluation of articular cartilage pathophysiology includes developmental techniques such as T1ρ and T2 relaxometry or magnetization transfer MRI [2] . These techniques enable a refined structural view of the cartilage and hence have significant diagnostic value [3] . However, they cannot offer information about the cell and molecular biology that underlies and precedes the structural changes.
Modern musculoskeletal radiology also makes use of radiolabeled tracers for nuclear imaging. Examples include 99m Tc-or 111 Inlabeled leukocytes and 99m Tc-methyl diphosphonate (MDP) for imaging infection and bone turnover, respectively. Although these techniques are clinically useful, they have low specificity, which limits their diagnostic value. For instance, 99m Tc-MDP exhibits affinity for bone mineral and accumulates in the skeleton preferentially at sites of altered bone turnover. Thus, it is a radiotracer that provides little information about the cells at work that ultimately control bone turnover.
This review was compiled under the following guidelines. In contrast to the mostly anatomic imaging described already, the main focus is on biomarker studies that aim at the direct
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visualization of musculoskeletal cells at work. However, other studies were also included if we thought they were of particular relevance to the field. We excluded molecular imaging of skeletal cancer, because a recent overview of this topic is available [4] . With the radiologist as reader in mind, the sections in this review are organized by imaging technique.
Techniques in Musculoskeletal Molecular Imaging

Optical Imaging
Although most current clinical molecular imaging approaches have their origin in conventional imaging, the application of optical imaging to in vivo biology has grown in parallel with the field of molecular imaging, and optical imaging is considered the technique with the highest throughput for preclinical molecular imaging. Indeed, optical imaging is the most commonly used technique for musculoskeletal molecular imaging (Table 1) . Optical approaches are based on the detection of emitted photons using external cameras and can be broadly categorized into fluorescence-and non-fluorescence-based imaging systems. Fluorescence refers to a physical property of molecules that are able to absorb light of a specified wavelength and to subsequently emit light of a longer wavelength. The transmission of incident photons through biologic materials is determined by the proportion that are reflected, scattered, or absorbed [5] . Although the degree to which photons are reflected is based on the angle of the incident light beam relative to the tissue surface, scattering and absorption are functions of the wavelength. As a result, there are significant limitations to the transmission of light from the ultraviolet through the infrared ranges (10-750 nm) and above 1300 nm; however, light absorption through biologic tissues decreases significantly at wavelengths longer than approximately 600 nm, reaching a minimum near 750 nm [6] . Hence, optimal tissue penetration can be achieved at this wavelength (up to 10-15 cm), and all fluorescence-based techniques reported for musculoskeletal molecular imaging use near-infrared (NIR) fluorophores [7] . The preponderance of non-fluorescence-based optical imaging techniques used for musculoskeletal molecular imaging apply bioluminescence. Bioluminescence imaging is based on the expression of the luciferase enzyme, which catalyzes the conversion of luciferin, a den o sine tri phosphate, and oxygen to oxyluciferin, a den o sine monophosphate, pyrophosphate, carbon dioxide, and visible light. Because the bioluminescent signal lies within the visible range, this approach is also limited by issues of penetration resulting from tissue absorption. 
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Optical modalities offer unique benefits, including user-friendly imaging systems and superior temporal resolution with high throughput for noninvasive imaging in small-animal models. The issues associated with absorption and scatter of incident photons by biologic materials limit the use of these approaches for noninvasive imaging in the clinic; however, tomographic approaches using fluorescence-based optical techniques may enable sufficient tissue penetration to image superficial regions, including joints, in patients. Despite their limitations for noninvasive imaging, optical approaches hold great promise for applications in musculoskeletal surgery, and minimally invasive procedures are already in development for use with oncologic and cardiovascular interventions.
Nuclear Imaging
Nuclear imaging plays an integral role in clinical imaging of the skeleton and has found broad application for musculoskeletal molecular imaging. Nuclear imaging approaches are based on the detection of radiation emitted from unstable isotopes that are administered in their free form or as an incorporated label in a larger compound. The type of radiation emitted depends on the mechanism of decay that a particular isotope uses to achieve stability. The most commonly used isotopes, for both research and clinical applications, decay through gamma ray emission (e.g., 99m Tc and 111 In) or positron emission (e.g., 18 F). The instrumentation required for nuclear imaging is determined by the type of decay used by the isotope of interest and includes gamma cameras, SPECT, and PET.
Nuclear imaging provides high sensitivity with unlimited depth, and imaging systems are widely available in small-animal imaging formats; however, although tomographic imaging is widely available, spatial resolution is limited. Furthermore, although many radiotracers are commercially available, targeted radiolabeled compounds often require inhouse radiochemistry for their synthesis [8] .
MRI
MRI plays a central role in the clinic for the detection of musculoskeletal pathologic abnormalities. Clinical MRI protocols are designed to detect disease through changes in anatomy, fluid levels, or contrast enhancement. These changes are primarily delineated on the basis of differences in water and fat content through measurement of signals generated from the water and fat hydrogen nuclei in vivo. Although MRI has played an important role in facilitating the development of musculoskeletal molecular imaging in smallanimal models, these approaches have been largely limited to the adaptation of hydrogen-based techniques for the purposes of cell tracking. The anatomic detail offered by MRI has led to the development of multimodality molecular imaging approaches, including integration with PET and optical approaches. Importantly, exciting developments in solidstate MR imaging techniques promise to enable unique insights into the structure, function, and physiology of calcified tissues, the evaluation of which was previously considered the purview of radiography and CT [9] . In addition, improvements in technology, such as higher magnetic field strengths and advanced electronics, may enable the broader application of more functional MRI approaches, including spectroscopic imaging of MRI-visible but less sensitive heteronuclei, such as 19 F, 31 P, or 13 C. Moreover, the development of dynamic nuclear polarization offers the potential for nearly real-time signal acquisition by increasing the detection sensitivity of 13 C-labeled molecules in solutionstate MR spectroscopy by more than 10,000 fold [10] . Although the costs associated with MRI-based approaches are higher than those for other modalities, the importance of MRI for evaluating musculoskeletal pathologic abnormalities in patients underscores the potential for translation of preclinical MRI paradigms. The main advantages of MRI are high resolution and unlimited depth. In addition, MR spectroscopy is unique in its capability for absolute quantitation; however, conventional MR spectroscopy has relatively low sensitivity and limited temporal resolution. Furthermore, MRI-based approaches are complex and require collaboration with experienced MRI scientists.
Ultrasound
Ultrasound is playing an increasingly important role in clinical musculoskeletal imaging; however, ultrasound approaches in musculoskeletal molecular imaging have been limited despite their rapid growth in other areas of molecular imaging [11] . Conventional ultrasound provides anatomic images that are acquired through the transmission of short sound pulses into the body. These sound waves can be reflected, refracted, or absorbed, and ultrasound provides anatomic information based on the degree to which each of these phenomena are present. The development of microbubble contrast agents offers the potential for functional sonography. Ultrasound microbubbles are gas-filled microbubbles 1-4 µm in diameter that can be modified through covalent or noncovalent attachment of targeting moieties to the microbubble shell.
Ultrasound-based approaches provide excellent spatial and temporal resolution at low cost. The continued development of microbubble contrast agents is expected to make ultrasound more relevant to musculoskeletal molecular imaging.
Molecular Imaging of Bone Turnover and Repair
Traditional anatomic imaging provides limited information about bone biology. Radiographs and CT provide assessment of bone mineral density but provide few hints as to the degree of active bone turnover. Understanding the physiology of bone turnover is critical to early recognition of and early intervention for bone disease. Molecular imaging offers insight into the cell and molecular biology behind bone turnover and, therefore, identifies potential targets for the monitoring and treatment of metabolic bone disease, bone repair, and osteolysis.
Optical Imaging of Bone Turnover and Repair
Optical imaging has emerged as a powerful method for studying bone biology in vivo. Kozloff et al. [12] studied osteoclast activity in vivo with fluorescence molecular tomography. Mice expressing an NIR fluorophore-labeled probe activated by cathepsin K, a marker of osteoclast activity and bone resorption, underwent ovariectomy to trigger estrogen deficiency-induced bone resorption. A subset of the mice were injected with an NIR fluorophorelabeled bisphosphonate developed by Zaheer et al. [13] , allowing monitoring of bone formation and resorption in parallel. The results provided a longitudinal evaluation of osteoblast and osteoclast activity and showed that, after insult, osteoclast activity returned to normal before that of osteoblasts. Alternative methods of imaging osteoblasts and osteoclasts have subsequently been proposed, such as a pH-activated osteoclast probe and a tetracycline derivative that specifically binds to mineralized bone during remodeling [14, 15] . Further study of these agents is needed to determine their relative strengths and weaknesses.
In earlier studies, Bar et al. [16] first showed the power of optical imaging for in vivo study of osteoblast activity. Transgenic mice expressing a luciferase marker gene under regulation of the osteocalcin promoter, a marker of osteoblast activity, underwent long
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bone fracture or femoral bone marrow ablation. The results showed that osteocalcin expression and, hence, osteoblast activity peaked at the sites of insult at 6 days and declined at 14 days. Osteocalcin is a critical component of the bone extracellular matrix and is secreted by osteoblastic cells. More recently, Nakanishi et al. [17] introduced an alternative human osteocalcin-luciferase construct into transgenic mice. They then showed through bioluminescence imaging that osteocalcin expression was higher in young mice compared with older mice. Furthermore, using a radius skeletal repair model, they showed that, although both young and old mice had increased osteocalcin expression at the fracture site, the expression was delayed in older mice compared with younger mice [17] .
The musculoskeletal system is ultimately influenced by hormonal regulation; therefore, functional imaging of hormonal activity as it pertains to the musculoskeletal system presents yet another avenue of research. Ciana et al. [18] studied the effects of estrogen on multiple organ systems, including the musculoskeletal system, by studying a luciferase reporter gene under the control of activated estrogen receptors. Their results showed that estrogen receptor activity in nonreproductive tissues, including the musculoskeletal system, is partly estrogen independent.
By enhancing our understanding of the biology of bone turnover, optical imaging techniques may contribute to the development of new methods for the promotion of bone healing. The current reference standard in clinical practice for promoting bone healing is autologous bone grafting. Optical imaging methods have shown the importance of systemic recruitment of mesenchymal stem cells (MSCs) and osteoprogenitor cells to sites of injury in bone healing. By use of a tibial fracture mouse model, Granero-Moltó et al. [19] showed the recruitment of luciferase-expressing transplanted MSCs to the site of injury and correlated this with improved callus formation. Gibon et al. [20] reported similar findings using further differentiated osteoprogenitor cells. They used bioluminescence imaging to show the migration of systemically administered immature osteoblasts (MC3T3-E1 cells) to the site of femoral injury in a mouse and correlated this finding with improved healing [20] . The enhancement of these physiologic processes may someday offer an alternative to bone grafting for promotion of bone repair.
Optical imaging has also played an important role in the development of gene therapy techniques for bone repair and bone regeneration in animal models. Techniques for achieving bone repair include in vivo delivery of bone growth factors, delivery of naive MSCs, and ex vivo delivery of bone growth factors [21] . For each of these methods, imaging is critical to confirm successful transfer of genes and or cells and to monitor therapy over time. Although optical imaging methods for imaging bone turnover have been vital to understanding the biology of bone turnover, the limitations of optical imaging make it unlikely that these techniques can be directly applied to human subjects in the near future.
Optical Imaging of Osteolysis
Osteolysis in joint replacement is an important clinical problem given the increasing demand for joint replacements. Optical imaging models of joint replacement-associated osteolysis have been developed and offer an opportunity to better understand this phenomenon. Ren et al. [22] injected cement particles into the femur of nude mice and found the accumulation of luciferase-expressing macrophages at the site of particle injection. Takahashi et al. [23] implanted polyethylene particles into the calvaria of nuclear factor κ-B (NFκB) ligand-transgenic and luciferase-transgenic mice. NFκB is a transcription factor involved in inflammation and is thought to play a role in osteoclastogenesis. The results of Takahashi et al. showed peak luminescence on day 7 at the site of implantation, indicating inflammation and osteoclastogenesis, and these findings correlated with bone resorption on micro CT.
Nuclear Imaging of Bone Turnover
The most common nuclear imaging methods for evaluating bone include SPECT using 99m Tc-MDP and PET using 18 F-FDG or 18 Ffluoride. The accumulation of 99m Tc-MDP in bone may reflect osteoblast activity, although uptake can also vary according to blood flow, capillary permeability, pH, bone mineral density, and hormonal input. FDG PET often reveals increased uptake in bone; however, this is a reflection of metabolic activity and does not necessarily reflect bone turnover.
The isotope 18 F-fluoride represents an alternative PET agent, which reflects osteoblastic activity. It accumulates in a manner similar to that of 99m Tc-MDP. Silva et al. [24] used 18 Ffluoride to image the effects of fatigue loading on the rat ulna. Using serial PET, they found that uptake was proportional to the degree of initial fatigue loading and peaked at 1 week. Since that time, 18 F-fluoride has been applied clinically to evaluate a wide range of abnormalities, including metastatic disease, metabolic bone disease, back pain, and child abuse [25] .
Although currently available nuclear medicine techniques provide information about bone turnover, efforts at identifying morespecific techniques are under way. Sprague et al. [26] imaged parathyroid-induced osteolysis in the calvaria of mice using 64 Cu-labeled arginyl-glycyl-aspartic acid, which binds to α v β 3 , an integrin expressed by osteoclasts. They found specific uptake of the agent by osteoclasts. In a further study, before undergoing imaging with arginyl-glycyl-aspartic acid, mice were pretreated with either osteopro tegerin to suppress osteoclastogenesis or with receptor activator of NFκB ligand to stimulate osteoclastogenesis [27] . Mice treated with osteoprotegerin showed decreased tracer uptake, whereas those treated with receptor activator of NFκB ligand showed increased uptake, further supporting the use of α v β 3 as a biomarker for imaging osteoclasts. Such an agent has potential application in monitoring diseases of bone turnover, such as osteoporosis and Paget disease, as well as inflammatory, infectious, and malignant bone disease. Furthermore, because osteoblastic agents such as 99m Tc-MDP often overlook primarily lytic osseous lesions, an osteoclast imaging agent broadens the diagnostic realm of musculoskeletal nuclear imaging.
MRI of Bone Turnover
Current clinical MRI techniques for evaluating the musculoskeletal system rely on measuring proton relaxation and density. Although MRI provides high-quality anatomic imaging, it provides little information about bone cell activity.
The combination of PET/MRI scanning would present one possible method for simultaneously obtaining anatomic and physiologic information with regard to bone turnover. It may also be possible to simultaneously obtain anatomic and physiologic information about bone turnover with the use of emerging MRI techniques alone, as outlined in a recent article by Gade et al. [28] , who imaged the activity of alkaline phosphatase, a commonly used clinical marker of bone turnover, using 19 F-MR spectroscopic imaging. Alkaline phosphatase-mediated hydrolysis of a small imaging molecule (6,8-difluoro-4-methylumbelliferyl phosphate) was tested on osteoblastic cells and bone tissue. Their results showed anatomically accurate imaging of alkaline phosphatase activity in bone cells. This technique provides a possible method for noninvasive and quantitative imaging of bone cell activity going forward.
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MRI of Bone Repair
MRI has also been used for the in vivo assessment of bone repair. Labeling stem cells with superparamagnetic iron oxides (SPIOs) before injection allows a method to track stem cells on subsequent noninvasive MRI. These particles may either attach to the cell surface or enter into the cells and are visible on ironsensitive T2-weighted gradient-recalled echo sequences as signal void. Jing et al. [29] visualized bone marrow MSCs labeled with SPIOs by MRI after intracavitary injection into rabbit knee joints. van Buul et al. [30] created cartilage defects in porcine osteochondral plugs and injected SPIO-labeled human bone marrow MSCs into the defects. The extent of signal loss was proportionate to the number of injected cells, and the SPIOs were not found to A-D, Injected cells were visualized in dose-dependent manner (in-plane resolution, 273 × 273 µm; slice thickness, 600 µm). Cells were found scattered throughout joint (arrows, B-D) and could be discerned from intraarticular structures. b = bone, c = cartilage, CL = cruciate ligament. E-I, Labeled cells implanted in cartilage defects in vitro were homogeneously distributed and imaged in comparable way. They are dose dependent and clearly distinguishable from structures like cartilage and bone (in-plane resolution, 78 × 78 µm; slice thickness, 1500 µm). J, After implanting cells in cartilage defect in intact porcine knee, MRI showed cells inside defect (in-plane resolution, 273 × 273 µm; slice thickness, 400 µm). Adapted with permission from [30] .
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impair the chondrogenic capacity of bone marrow MSCs [30] (Fig. 2) . There are conflicting data in the literature on the subject of whether SPIOs exert a negative effect on chondrogenic differentiation of bone marrow MSCs, perhaps because of variation in methods [31] [32] [33] [34] . Saldanha et al. [35] performed similar research, using micrometer-sized paramagnetic iron oxide to label rabbit bone marrow MSCs, which were injected into an ex vivo bovine osteochondral knee defect model. Their research also showed successful MRI visualization of labeled bone marrow MSCs within cartilage, although iron aggregation hindered visualization of the extracellular matrix. Effective noninvasive means of imaging is critical to the advancement of stem cell-based therapy, and, therefore, there is great potential for the use of SPIO-labeled bone marrow MSCs in the clinical setting. However, clinical relevance of stem cell therapy for bone repair still awaits robust clinical evaluation.
Molecular Imaging in Joint Disease
Osteoarthritis, or degenerative arthritis, is one of the most prevalent chronic joint diseases. Osteoarthritis is associated with, but not caused by, aging, and most people older than 65 years will experience the disease in some form. Symptoms include joint pain, swelling, and stiffness after inactivity. In osteoarthritis, chondrocyte activation in the absence of apparent inflammation results in an imbalance of cartilage matrix turnover and changes in subchondral bone. In comparison, RA is an inflammatory autoimmune disease and typically progresses more rapidly than osteoarthritis. RA leads to highly vascularized inflamed joints (synovitis) and to the destruction of cartilage and, eventually, underlying bone. The acuteness of RA has garnered it much attention in the field of joint imaging. What is known of the biochemical pathway of RA offers many promising targets for musculoskeletal molecular imaging, such as the infiltration or immune cells and protease activity.
Improving the sensitivity of early-detection methods and close monitoring of treatment response are central to arthritis management and are essential to guiding early intervention before irreversible damage occurs [36, 37] . Current diagnosis relies heavily on clinical assessment of swelling and joint pain, which can be rather subjective. Conventional radiographic methods also play a role in diagnosis but rely on the detection of findings that occur late in the disease process, such as bone erosions and narrowing of joint space [37] . CT and MRI provide a more-detailed depiction of the underlying processes of joint disease but still fail to capture the cellular biology that cause disease onset and progression. Early diagnosis of joint diseases could become the primary clinical application for molecular imaging. It has been proposed that optical techniques, in particular, may prove a useful and affordable alternative to conventional radiography but need to offer quantifiable parameters for clinical assessment [38] .
Optical Imaging of Macrophage Infiltration and Molecular Markers of Inflammation
NIR fluorescent agents have found frequent application because of the good tissue penetration properties of the detected light and low autofluorescence of surrounding tissues [39] . Hansch et al. [40] investigated optical imaging of RA by NIR fluorophore-labeled antibodies by using an antibody-coupled fluorochrome Cy5.5 dye targeted to the F4/80 macrophage-antigen in a murine antigen-induced arthritis model. No antigen specific to arthritic joints had been identified, requiring comparison with healthy joints. The goal was to track macrophages invading the inflamed joint, but the antibody-linked dye bound to macrophages in other organs, specifically the liver. As an alternative, Hansch et al. [41] also turned to nonspecific imaging exploiting the "leakiness" of inflamed joints, on the basis of the same animal model and the Cy5.5 dye alone. They found that the dye accumulated in the inflamed synovial membrane as a result of high blood perfusion and albumin binding. Detection was optimal 12 hours after dye injection, and the dye was present for 72 hours after the experiment; thus, the potential toxicity of the dye and low spatial resolution are possible drawbacks of the method.
Chen et al. [42] used an NIR fluorophoreconjugated folate as a probe for imaging RA in two mouse models. An isoform of the folate receptor can be found expressed on activated, but not resting, macrophages in the synovium. They found that nonlinked NIR fluorophoreconjugated folate dye was taken up by macrophages, but most of the free dye was washed out within 72 hours, whereas the folate-linked dye remained present. Folate targeting has also been used in nuclear imaging [43] and will be discussed separately in this article.
Gompels et al. [44] investigated the use of endothelial leukocyte adhesion molecule 1 (Eselectin) as a specific endothelial marker in arthritis. E-selectin is expressed in response to proinflammatory cytokines involved in RA and is upregulated in inflammatory synovitis. Monoclonal E-selectin antibodies were labeled with an NIR fluorophore (DyLight 750, Thermo Fisher Scientific). Fluorescence imaging was performed in a mouse model of paw edema generated by local injection of tumor necrosis factor, as well as in mice with collagen-induced arthritis. The authors claimed that paws that did not develop arthritis (e.g., clinical score of 0) showed fluorescence and concluded that their imaging method had high sensitivity for early detection. However, the results could be due to an unrelated effect, because the mechanisms of early arthritis are not well understood.
More recently, Qi et al. [45] introduced a novel nanovesicle-based agent for imaging joints in RA. Saposin C is a membrane-associated lysosomal protein with a high affinity for phosphatidylserine-enriched microdomains on cell membranes surfaces. Saposin C was incorporated into dioleoyl-phosphatidyl serine (DOPS) lipid nanovesicles together with an NIR fluorophore fluorescent dye (CellVue Maroon, Polysciences). They used two mouse models-serum-transfer arthritis (K/BxN mice) and collagen-induced arthritis-with distinct progression and cause. The saposin C-DOPS-fluorescent dye vesicles were localized to arthritic joints and were imaged in vivo. Measured saposin C-DOPS intensity correlated with independent arthritic parameters and disease severity. Analysis using fluorescence-activated cell sorting pointed to CD11b + Gr-1 + joint cells as the primary target. The authors hoped to use the vesicle system to include other imaging agents for specific delivery. One potential drawback could be localization of saposin C-DOPSfluorescent dye to the liver and spleen, a side effect shown in a previous study [46] . Also recently reported were arthritic therapeutics that exhibit autofluorescence in the NIR region. Palframan et al. [47] investigated the distribution of three such agents in rats with collagen-induced arthritis.
Optical Imaging of Joint Proteolysis
Another group of imaging dyes relies on activation by proteases. Proteolysis in arthritis has been linked to dysregulation of proteinases, such as matrix metalloproteinases (MMPs) and cathepsins [48, 49] . In 2004, Lai et al. [50] were among the first to use a cathepsin B activity-based NIR probe in a local osteoarthritis mouse model based on intraarticular injection of bacterial collagenase. Before activation by proteolysis, interactions between the closely spaced fluorochromes Wilmot et al.
quench their fluorescence. After systemic administration of the Cy5.5-labeled poly-l-lysine backbone probe, arthritic joints showed a substantial NIR fluorescence, and quantitation showed an approximately threefold increased signal compared with the control, allowing detection of very early stage osteoarthritis. In the same year, Wunder et al. [51] used the same dye probe and mouse model to quantify the therapeutic response to the antiproliferative drug methotrexate in vivo.
Cathepsins continue to serve as an interesting target for activity-based probes. Recently, Caglič et al. [52] developed an NIR-quenched fluorescent substrate (AW-091) for cathepsin S, a cysteine peptidase, in a mouse model of inflammatory paw edema. Fluorescent signal could be observed in vivo earlier, although at a lower intensity, than that for a commercial cysteine cathepsin substrate (ProSense 680, PerkinElmer). The fluorescent signal from cleaved AW-091 was reduced in the presence of the antiinflammatory drug dexamethasone and a cathepsin inhibitor. Recently, Ryu et al. [53] used an MMP-3-specific polymeric probe in an NIR imaging study of mice with collagen-induced arthritis. To track MMP-3 in vivo, they conjugated a commercial NIR fluo rophore (Flamma FPR-675, BioActs) to an MMP substrate peptide and conjugated a dark quencher (Black Hole Quencher-3, Biosearch Technologies) to self-assembled chitosan nanoparticles. Specific substrate recognition by MMP leads to cleavage of the quenched probe and to significant recovery of fluorescence signals. Although Ryu et al. found that the probe was responsive to both MMP-3 and MMP-7, they determined that the amount of secreted MMP-7 was much lower than that of MMP-3. They were able to detect an NIR fluo rescence signal before any signs of anatomic changes due to arthritis (as observed by histologic analysis and micro CT) and attributed this result to both high vascularization, leading to quick accumulation of the nanoparticle probe, and elevated MMP-3 activity. In a control, the unbound peptide probe (without chitosan nanoparticles) also showed fluorescence in collagen-induced arthritis mice, but at lower intensity and for a shorter time. The authors suggest that their findings may have applications for combined drug delivery and imaging of therapeutic response.
Nonspecific Optical Imaging of Macrophage Infiltration and Molecular Markers of Inflammation
Knowing that inflammatory processes are associated with high local concentrations of reactive oxygen species, Chen et al. [54] used reactive oxygen species as markers in an animal model of arthritis, detected by a luminol-based chemoluminescence reaction.
In 2006, Fischer et al. [55] imaged the ankle joints in a Lyme arthritis mouse model, using two nonspecific NIR carbocyanine dyes. The goal was to identify an NIR fluorophore similar to contrast agents used in MRI. The first dye, indocyanine green (ICG), is one of a few NIR dyes approved for clinical use by the U.S. Food and Drug Administration. The study was intended to show its applicability to nontargeted in vivo imaging of arthritis in humans. ICG shows high tissue plasma affinity, and a hydrophilic derivative, 1,1'-bis-(4-sulfobutyl)indotricarbocyanine-5,5'-dicarboxylic acid diglucamide monosodium salt, with low plasma-binding affinity was tested as an alternative. The interval of image acquisition was very short (2 minutes), which posed a problem for quantification. Both dyes enabled significant differentiation of healthy and inflammatory joints; 1,1'-bis-(4-sulfobutyl)indotricarbocyanine-5,5'-dicarboxylic acid diglucamide monosodium salt allowed differentiating inflammatory and noninflammatory joints 24 hours after dye injection because of slower elimination. Very recently, this optical imaging method moved beyond the preclinical stage, simply by virtue of using a clinically approved dye, despite its nonspecificity and low retention. ICG has since been used as a nonspecific contrast agent to clinically detect RA by imaging [55] . Its distribution kinetics in different patients have been analyzed statistically [56] . Compared with MRI, it was found that that ICG-enhanced imaging of 45 patients allowed only limited detection of inflamed joints in the hand, especially for early stages and mild synovitis [57] , although another study found ICG-enhanced imaging comparably informative [58] .
Optical Imaging of Arthritic Gene Expression
Over a decade ago, Carlsen et al. [59] genetically modified mice with a luciferase bioluminescence imaging reporter under control of three NFκB sites. They used antibodies to induce chronic inflammation in the mice and found that luciferase activity in transgenic mice was observable during the inflammatory process. Izmailova et al. [60] investigated NFκB signaling during inflammatory responses by NIR imaging. They used the transgenic mice created by Carlsen et al. for imaging NFκB activity in structures in close proximity to the surface, such as skin and joints in extremities. NFκB is regulated by the IκB kinase-2, which can be inhibited by a small molecule, ML120B. A large increase in fluorescence signal intensity was observed in the joints of arthritic animals, but signal intensity was attenuated in the presence of ML120B, indicating that, in vivo, NFκB is regulated by the IκB kinase-2. Despite their great value as preclinical research tool, clinical application of the imaging techniques discussed in this section is currently hampered by the need for in vivo gene transfer.
Nuclear Imaging of Joint Metabolism, Macrophage Infiltration, and Proteolysis
The most frequently used PET radiotracer at present is FDG, a glucose analog that allows tracking of glucose metabolism. Inflamed arthritic joints show an increased metabolic rate, resulting in increased uptake of FDG [61] . Because the pathologic process of RA shares characteristics with those of other inflammatory diseases, a string of radiotracers used previously for diagnostic imaging in other conditions is currently under investigation for diagnostic imaging of RA [37] .
Macrophages, which abound in inflamed arthritic joints, have attracted great attention as an accessible source for imaging biomarkers in arthritis. For almost a decade, the folate receptor on macrophages has been a popular target for scintigraphy and SPECT studies using a radioactive folate tracer [43] . Saborowski et al. [62] targeted the folate receptor with a specific gadolinium-chelate contrast agent for use in MRI. In an osteoarthritis rat model, Piscaer et al. [63] targeted the folate receptor-β by SPECT, which allowed macrophage localization with high sensitivity and high resolution.
Macrophages in synovial tissue are constantly replaced by circulating monocytes. In a scintigraphic study of RA, Thurlings et al. [64] isolated CD14 + monocytes and labeled them with 99m Tc-hexamethyl-propyleneamine oxime followed by reinfusion. Their findings suggested that antirheumatic treatment led to a decrease in macrophage numbers because of a change in macrophage retention rather than a decrease in monocyte influx. A recently developed PET probe, 11 C-PK11195, acts as a selective ligand for the peripheral benzodiazepine receptor on activated microglial cells. This probe may allow detection of subclinical arthritis by PET [65] .
Another novel molecular probe based on pyrimidine-2,4,6-triones [66, 67] targets MMPs,
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which play a significant role in proteolytic activity in arthritic joints [48] . So far, the tracer has displayed favorable pharmacokinetics for detection by PET, but it still has to be further tested in preclinical models of arthritis.
Molecular Imaging of Skeletal Infection
The traditional diagnostic radiologic techniques (radiography, CT, ultrasound, and MRI) provide rich anatomic information but are nonspecific for the detection of musculoskeletal infections. In isolation, these techniques cannot reliably differentiate between infectious musculoskeletal processes and noninfectious inflammatory processes.
Molecular imaging is enriching our understanding of the pathophysiology behind musculoskeletal infections. Furthermore, molecular imaging research has the potential to yield sensitive and specific tests for detecting musculoskeletal infection, as well as methods of delivering targeted therapy and monitoring therapy noninvasively.
Optical Imaging of Osteomyelitis
Optical imaging is unlocking important details regarding the pathophysiology of musculoskeletal infection. Many optical imaging studies have been modeled on postarthroplasty infections. Postarthroplasty infection is an important clinical problem because it affects approximately 1% of all joint arthroplasties [68] . The demand for joint arthroplasties is growing and is expected to reach 3.8 million procedures annually by 2030, which means that the number of annual cases of arthroplasty-related joint infections could exceed 250,000 [69] .
In a mouse model providing insights into the pathophysiology of postarthroplasty infection, Li et al. [70] implanted stainless steel pins coated with luxA-E-transformed, and hence bioluminescent, Staphylococcus aureus into the tibia of mice. Imaging the light emission from the bacterium allowed monitoring of the kinetics of bacterial growth, and these findings were correlated with serologic and histologic results and micro CT findings. Bacterial growth was exponential during the first 4 days, followed by lower metabolic rate with biofilm formation from days 4 through 11. At day 11, bacterial load began to decrease, correlating with the emergence of a specific IgG2b response against S. aureus proteins.
Further modeling of the pathophysiology of musculoskeletal infection has included a study that compared bioluminescence signals from S. aureus strains with three basic bioluminescent constructs: an antibiotic selection plasmid, a stable plasmid, and direct integration into the bacterial chromosome. The stable plasmid showed the highest signal at day 42, making it superior for use in studying chronic infection [71] . Bernthal et al. [72] showed the protective function of interleukin-1B in early defense against bacterial infection, with the likely mechanism being neutrophil recruitment to the site of infection.
In addition to elucidating the pathophysiology of musculoskeletal infection, molecular imaging has shown promise in studying methods to prevent infection. Bernthal et al. [73] implanted stainless steel K-wires with and without an antibiotic-impregnated polymer into the distal femur of mice, followed by inoculation with bioluminescent S. aureus. In mice with antibiotic-impregnated polymer, bioluminescence levels reduced to background levels by day 3, and histologically there was no evidence of biofilm formation. Mice without the antibiotic-impregnated polymer had bioluminescence levels 50 times higher than those of the mice with the polymer by days 5-7, had greater guarding with walking, and also had evidence of biofilm at histologic analysis. In addition, enhanced green fluorescence protein-neutrophil fluorescence was monitored in both groups and was higher in the nonpolymer group [73] . The findings supported efficacy of the antibiotic-impregnated polymer in reducing infection. In the initial experiment, bioluminescence signals were coregistered with 2D x-rays, providing suboptimal visualization and measurement of bone damage. Subsequently, Niska et al. [74] performed research with a similar model, this time coregistering the luminescence signals with micro CT. Again shown was the ability of the antibiotic-impregnated polymer to reduce infection, whereas the use of micro CT provided superior visualization and measurement of bone damage.
Although antibiotic polymers may decrease the burden of postarthroplasty infection, an optical imaging study by Li et al. [75] found that antiresorptive agents, anecdotally used by some orthopedists to minimize periimplant osteolysis, may in fact be detrimental to therapy. Their study showed increased susceptibility to high-grade osteomyelitis in mice undergoing antiresorptive therapy, likely due to decreased resorption of necrotic bone.
Finally, although the models discussed here all simulate postarthroplasty infection, Funao et al. [76] created a model in which S. aureus was inoculated directly into the femur via a drilled hole, which may provide a more accurate model of non-arthroplasty-related osteomyelitis.
Overall, the strengths of bioluminescence imaging in the study of joint infection include its ability to elucidate the pathophysiology of infection and to allow targeted interventions and modeling of therapy. Ultimately, current bioluminescence imaging is restricted to small animals and is not practical in humans. However, although bioluminescence imaging cannot be reproduced in humans, the generalizable findings from bioluminescence imaging, such as the efficacy of antibiotic-coated polymers in preventing postarthroplasty infections, will be critical in advancing clinical treatment.
Nuclear Imaging of Osteomyelitis
Nuclear imaging for osteomyelitis shares many of the theoretic strengths of optical imaging, such as the ability to image physiology. Like optical imaging, nuclear medicine also offers the potential to target molecular processes for intervention. Although optical imaging is limited to small-animal research, nuclear imaging techniques can be applied directly to humans.
Current clinical applications of nuclear medicine in the diagnosis of infection include nonspecific methods for imaging inflammation, such as the use of labeled white blood cells. Multiple avenues are being pursued to achieve a more specific method of imaging infection. These include radiolabeled antimicrobial peptides and radiolabeled antibiotics.
The tracer 99m Tc-UBI 29-41 is an example of an antimicrobial agent. In a study of infected rabbit thighs, this agent showed efficacy in both diagnosis of infection and monitoring of therapy [77] . One drawback of this agent in a human clinical trial was a low target-tobackground ratio [78] ; 99m Tc-labeled human b-defensin 3 has shown good target-to-background ratio and antimicrobial activity in an early investigation [79] . Although antimicrobial agents may ultimately provide a specific method for diagnosing musculoskeletal infections, these methods may have low sensitivity. For instance, if imaging for an antimicrobial peptide expressed by S. aureus is negative in a patient with suspected osteomyelitis, this would not rule out infection altogether; a different microorganism that does not express the peptide could be the culprit.
The search for a highly sensitive and specific method of nuclear medicine imaging for infection is ongoing, and these avenues of research offer great promise both in terms of diagnostic and therapeutic possibilities.
Molecular Imaging of Peripheral Pain Generators
According to an Institute of Medicine report in 2011 [80] , approximately 100 million
Wilmot et al.
people in United States have chronic pain. The annual cost of medical treatment and lost productivity of patients with chronic pain is estimated to be more than $550 billion [80] . A clinician's assessment of pain relies significantly on a patient's self-report, which can be highly subjective. Current clinical imaging, such as that acquired from CT and MRI scans, relies on finding anatomic abnormalities as the cause of pain. However, many studies have indicated that asymptomatic patients may also possess the same anatomic abnormalities with a similar prevalence [81] [82] [83] ; these findings render routine CT and MRI scans relatively nonspecific and, therefore, bring into question the accuracy of these imaging modalities in detecting pain-relevant pathologic abnormalities.
To improve our ability to "image pain," or perhaps, more accurately, to image pain-related nociceptive activity, a number of functional and molecular or cellular imaging approaches are currently being used and developed. The approaches exploit the physiologic, molecular, or cellular changes associated with enhanced nociceptive activity that occur anywhere along the nociceptive pathway in the peripheral nervous system and CNS in chronic pain states, some of which are summarized in Table 2 . For example, functional imaging methods that associate brain activity with changes in the local oxygenated blood flow, such as blood oxygen leveldependent MRI and 15 O-water PET, have defined the "pain matrix" in the brain. The matrix includes the primary and secondary somatosensory cortexes, insula, prefrontal cortex, and parietal association cortexes, thalamus, and certain brainstem nuclei. Because there are several excellent reviews on imaging of the pain matrix in the brain, the remainder of this section will focus on imaging peripheral manifestations on heightened nociceptive activity [84, 85] .
Centers in the brain and spinal cord undergo several maladaptive changes, including central sensitization, microglial cell activation, and synaptic plasticity, to create an environment for heightened sensitivity for pain sensations [86] . Similarly, peripheral sensitization is a hallmark of chronic maladaptive pain. Excitability of the nociceptive nerve is increased by action of inflammatory mediators, ion channel dysregulation, interactions with macrophages, and a number of modulatory events, ultimately resulting in features such as allodynia (pain from a noninjurious stimulus) and hyperalgesia (heightened pain sensation to a painful stimulus). The following paragraphs provide an overview of some of the molecular imaging methods, which exploit these changes in the peripheral nociceptive pathway, that are currently being developed and have the potential to image pain generators.
Nuclear Imaging of Glucose Metabolism and Sigma 1 Receptors
FDG is a well-known metabolic PET marker that follows glucose as it diffuses into the cell and gets trapped within the glycolytic cycle. Tissues with increased metabolism (such as malignant, infective, and inflammatory foci) show increased uptake of FDG. In chronic pain, continuously or spontaneously firing neurons, as well as any associated inflamed tissues, are hypermetabolic and, therefore, glucose avid. This phenomenon can be exploited to visualize increased neural metabolism in the nervous system using FDG PET/MRI. In a rat model of neuropathic pain, Behera et al. [87] could localize increased FDG uptake in injured nerves using PET/MRI. The FDG uptake correlated well with behavioral measurements of allodynia in the affected paw. In contrast, control nerves in the contralateral normal limb of the neuropathic subject or in the control asymptomatic animals showed significantly less FDG uptake (Fig. 3) . Increased FDG uptake in peripheral nerves has also been observed in patients. In one clinical case report, for example, a patient had "hot" lumbar spinal cord and sciatic nerves on FDG PET/CT scan. On biopsy, these neural structures showed pathologic signs of chronic neuropathy [88] .
Localizing sites of nerve damage may be another strategy to identify chronic or neuropathic pain generators. One possible strategy would be to assess sigma 1 receptor density. Sigma 1 receptors, which were once thought to be a subtype of opioid receptors and are present in many types of tissues, have an established role in the development and maintenance of chronic pain in the CNS [89] . These receptors are also abundantly expressed in Schwann cells and macrophages, which are 
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cells that proliferate in neural damage and are involved in repair and neural inflammation [90, 91] . Proinflammatory cytokines released by Schwann cells, macrophages, and other immune cells contribute to spontaneous nociceptive activity and central sensitization [92] . Thus, in the vicinity of the nerve injury, the combination of Schwann cell proliferation and the recruitment of macrophages at the site of neuroinflammation, along with a possible cellular upregulation of sigma 1 receptor expression, leads to a substantial increase in sigma 1 receptor density. Imaging probes directed to sigma 1 receptor can therefore help pinpoint sites of neuroinflammation that are related to pain generation. A highly specific radiolabeled sigma 1 receptor ligand, 18 F-FTC-146, has shown specific increased uptake in the neuroma caused by nerve injury in a neuropathic pain animal model. The tracer uptake correlated with sigma 1 receptor expression as well as Schwann cell proliferation seen with immunohistochemistry [93, 94] . Identifying sites of neural damage using methods such as the one just described may help identify sources of posttraumatic pain, postsurgical pain, complex regional pain syndrome, and other nerve injury and neuroinflammatory chronic pain disorders.
Nuclear Imaging of Voltage-Gated Sodium Channels
Voltage-gated ion channels are critical in action potential generation and propagation of the electrical signal along the nociceptive pathway. More specifically, the density of voltage-gated sodium channels is enhanced in injured and inflamed nerves [95, 96] ; this increase in voltage-gated sodium channel density is attributed to the frequent and spontaneous depolarizations associated with chronic pain. One of the central mechanisms of lidocaine, which is one of the most commonly used anesthetics, is through voltage-gated sodium channel blockade. Saxitoxin, which is well known for causing paralytic shellfish poisoning, has been recently modified and radiolabeled with 18 F, which binds to voltage-gated sodium channel with nanomolar affinity. A 40% increase in PET signal was seen in painful neuromas in a neuropathic pain model using 18 F-saxitoxin and PET/MRI [97] .
Nuclear Imaging of Voltage-Gated Calcium Channels
Calcium channels are also known to be upregulated in chronic pain and play an important role in action potential generation. During cellular depolarization, there is a significant amount of calcium influx followed by an efflux of calcium to help return the cell to its resting membrane potential. Manganese is a T1-shortening MRI contrast agent that physiologically follows calcium. Imaging contrast can be generated in hyperactive cells because the rate of manganese efflux is very slow and manganese accumulates in the cell. Manganese-enhanced MRI thus acts as a surrogate method of estimating calcium fluxes in neuronal cells, because cells that are electrically active will accumulate manganese intracellularly and, therefore, T1-weighted contrast agent over time. In a preclinical study using orally administered manganese, manganese-enhanced MRI highlighted the lumbar plexus of a sciatic nerve injury model. T1-weighted signal-to-noise ratios in sciatic nerves within the pelvis correlated well with manganese content in the nerves measured by inductively coupled plasma spectrometry [98] . Control uninjured animals showed significantly less T1-weighted manganese-enhanced MRI signal than did the neuropathic pain models, which correlated with behavior scores and lower manganese content as measured by inductively coupled plasma spectrometry.
MRI of Macrophage Trafficking
Another method of investigation relies on iron nanoparticle-labeled macrophage tracking with MRI. Macrophages and microglia play an important role in the repair of nerve damage. During this process, the release of inflammatory mediators by these cells adds to the pathogenesis of chronic pain by potentiating and maintaining heightened sensitivity of pain-sensing neurons. Localization of these pronociceptive cells near neural structures of interest may prove to be helpful in identifying pain generators. After IV injections of the iron oxide nanoparticles, macrophages engulf iron nanoparticles, and MRI can therefore be used to track their migration, because iron nanoparticles produce a strong MRI contrast as a result of their superparamagnetic properties. Ghanouni et al. [99] used ultrasmall SPIO (USPIO) MRI to show that macrophages did indeed traffic to a site of nerve injury in a neuropathic pain model; they found that USPIO-injected rats had reduced T2-weighted signal at the site of injury (Fig. 4) . Systemic administration of minocycline, which inhibits macrophage and microglial activity, significantly reduced the recruitment of macrophages to the neuroma, resulting in decreased pain behaviors [99] .
Combined with the excellent anatomic resolution of MRI, USPIO-laden macrophages highlight a method of identifying foci of chronic monocytic infiltration along nociceptive pathways in the nervous system. This method can be exploited to localize chronic pain generators and to help in the development of macrophage inhibitors as novel analgesics. Although human studies are yet to be performed on painful peripheral nerve imaging, both FDG and USPIOs are clinically approved molecular agents and are favorably positioned for clinical investigations.
Conclusion
Promises and Challenges in Imaging Bone Turnover, Damage, and Repair
Understanding the physiology of bone turnover is critical to early recognition of and early intervention for bone disease. Optical imaging has provided insights into the role of osteoblasts, osteoclasts, and stem cells in animal models of bone turnover, injury, and osteolysis. Optical imaging has also played a role in the development of gene therapy techniques for bone repair and bone regeneration in animal models. Although optical imaging is unlikely to have direct applications in humans, it provides a more thorough understanding of the physiology of bone turnover and repair, which, in turn, promotes new approaches to therapy.
Currently used nuclear medicine techniques provide indirect evidence of osteoblastic bone activity, using 99m Tc-MDP in the case of planar imaging and 18 F-fluoride in the case of PET. FDG PET shows the metabolic activity of bone. Efforts at identifying more-specific techniques of imaging bone turnover are under way, such as a peptide that binds to integrins on osteoclasts. Not only could such an agent provide more specificity in identifying sites of bone turnover, but because osteoblastic agents often overlook lytic osseous lesions, an osteoclast imaging agent also could broaden the diagnostic realm of musculoskeletal nuclear imaging.
MRI provides excellent anatomic depiction of the musculoskeletal system, but current clinical applications provide limited physiologic information. Combining PET with MRI provides one avenue for obtaining greater physiologic information on bone turnover and bone repair using MRI. Labeling molecules and cells involved in bone turnover and repair with agents that alter T1 and T2 properties (e.g., labeling stem cells with SPIOs) presents an alternative method to obtaining such physiologic information. Although such techniques await application in humans, in the future they may serve to facilitate diagnosis and monitoring of treatment in a wide range of musculoskeletal pathologic abnormalities.
Promises and Challenges in Imaging Joint Diseases
An array of optical imaging studies has begun to dissect key events in arthritic joint destruction, such as immune cell infiltration, proteolytic degradation, and inflammatory gene expression. Taken together, these studies represent the most comprehensive portfolio of biomarker imaging techniques currently available for any musculoskeletal tissue. They show that the distinct disease stages can be quantitatively visualized and that Fig. 4 -Representative sagittal fast imaging employing steady-state acquisition images of left and right thighs and sciatic nerve of rats with neuropathic pain obtained 7 days after spared-nerve injury. Rats were injected with ultrasmall superparamagnetic iron oxides (USPIOs) immediately after peripheral nerve injury and on day before MRI and received daily intraperitoneal minocycline injections. This dose and timing of administration has been shown to label macrophages. A and D, Rat received neither minocycline nor USPIOs. Sciatic nerve (arrow, A) shows increased signal intensity relative to surrounding muscle. Injured nerve was enlarged compared with uninjured side (data not shown). Low signal at distal truncated end of nerve corresponds to site of ligature. Control image of uninjured right nerve is shown (arrow, D) . B and E, Rat received USPIOs but not minocycline. There is iron-induced signal loss, because sciatic nerve (arrow, B) is nearly isointense to surrounding muscle. Low signal at distal truncated end of nerve corresponds to site of ligature. Control image of uninjured right nerve is shown (arrow, E). C and F, Rat received both minocycline and USPIOs. Signal intensity in sciatic nerve (arrow, C) is higher than with USPIOs alone, suggesting that minocycline retards migration of USPIO-laden macrophages to site of injury. Low signal at distal truncated end of nerve corresponds to site of ligature. Control image of uninjured right nerve is shown (arrow, F).
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musculoskeletal molecular imaging may indeed permit earlier and more specific diagnosis as compared with conventional diagnostic means. To date, the nontargeted NIR dye ICG is the only dye approved for molecular joint imaging in a clinical setting [55] [56] [57] [58] , but it has not shown much diagnostic impact over established MRI methods. To this end, it needs to be emphasized that understanding the pharmacokinetics of molecular imaging agents (plasma binding, specificity, and clearance) is of critical importance before any clinical application. Subsequent data analysis needs to be considered as well, to allow incorporation of optical detection techniques into the accepted framework of diagnosis (e.g., similar to the OMERACT Rheumatoid Arthritis MRI Scoring system) [37, 100, 101] . Finally, novel and more-specific radiotracers for nuclear imaging in joint diseases are being reported and may prove to be of particular relevance to future clinical applications.
Promises and Challenges in Imaging Skeletal Infection
From a theoretic standpoint, radiolabeled antibiotics would be expected to accumulate with specificity at the site of infection. However, the first such agent to be used clinically, 99m Tc-ciprofloxacin, has not shown consistent efficacy in this regard [102, 103] . There are numerous more recently developed technetium-labeled antibiotics, which include 99m Tc-alafosfalin and 99m Tc-cefuroxime axetil, many of which show promise but none of which has yet emerged as the desired sensitive and specific imaging agent [104] . Radiolabeling of antibiotics has extended beyond planar imaging to PET, with the development of agents such as N4F18-fluoroalkylated ciprofloxacin [105] .
MRI offers superior anatomic imaging for the assessment of musculoskeletal disease given its high soft-tissue contrast. However, traditional MRI techniques are by no means specific for diagnosis of musculoskeletal infection; rather, MRI findings must be interpreted in the context of clinical information. With the emergence of PET/MRI, there is the potential to combine the physiologic strengths of nuclear medicine with the superior anatomic information provided by MRI and potentially achieve a higher accuracy for diagnosis of infection than either modality can achieve alone.
Promises and Challenges in Imaging Peripheral Pain Generators
Although the recent spate of research into peripheral nerve imaging for chronic pain generators is encouraging, there are several limitations and challenges in the implementation of these approaches. Methods directed at ion channels are potentially toxic. Because typical radiotracer doses are well below the dose that produces any physiologic effect, PET-based methods currently offer the widest therapeutic window. Regardless, toxicity issues have to be addressed and safety standards have to be established before widespread clinical use. Other challenges include accounting for the subjective and affective components of pain, determining the accuracy of preclinical pain models when applied to the human pain experience, and imaging small structures of interest (e.g., dorsal root ganglia and peripheral nerves). These challenges can be addressed and perhaps overcome through further research.
By taking advantage of cellular, molecular, and physiologic changes in the nervous system, bones, and relevant soft tissues that are elaborated in pain states, we can develop more-objective markers of nociception and pain. Given the sensitivity and specificity of PET radiotracers and advanced MRI techniques (e.g., isotropic imaging for neurography and diffusion tractography), along with the high spatial and contrast resolution afforded by PET/MRI systems, we foresee this hybrid imaging modality leading the way in "imaging pain." The marriage of pain-relevant radiotracers, PET, and advanced MRI techniques may improve our ability to objectively identify pain generators and intelligently guide therapy. Should imaging pain prove to be successful and lead to improved methods of treatment, this could have a tremendous impact on the field of radiology, because there are millions of pain sufferers who would benefit from such an approach.
